Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of TTK protein | affects expression | 20106945
|
D006710 |
Homocysteine |
Homocysteine results in decreased expression of TTK mRNA | decreases expression | 17326132
|
D001374 |
Azacitidine |
[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA | affects cotreatment|affects expression | 18720364
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of TTK mRNA | decreases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TTK mRNA | decreases expression | 20382639 20018196
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of TTK mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of TTK mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of TTK mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TTK mRNA] | decreases reaction|increases expression | 17854601
|
D004317 |
Doxorubicin |
TTK protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004958 |
Estradiol |
Estradiol results in increased expression of TTK mRNA | increases expression | 20106945
|
D019833 |
Genistein |
Genistein affects the expression of TTK mRNA | affects expression | 18847459
|
C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of TTK mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in decreased expression of TTK mRNA | decreases expression | 15956246
|
C011890 |
kojic acid |
kojic acid results in decreased expression of TTK mRNA | decreases expression | 16595896
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of TTK mRNA | increases expression | 20713471
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of TTK mRNA | decreases expression | 18548127
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of TTK mRNA | decreases expression | 18955075
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of TTK mRNA | increases expression | 15674844
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in decreased expression of TTK mRNA | decreases expression | 15585362
|
C059514 |
resveratrol |
resveratrol results in decreased expression of TTK mRNA | decreases expression | 15767336
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TTK mRNA | decreases expression | 17998272
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TTK mRNA | decreases expression | 16714409
|
D013792 |
Thalidomide |
[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA | affects cotreatment|affects expression | 18720364
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of TTK mRNA | decreases expression | 17951470
|
D014747 |
Vinblastine |
TTK protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.20 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
8.20 | 8333272 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.71 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.88 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.88 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.88 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.88 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
15.30 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
15.30 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
15.30 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
15.30 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.55 | 17620307 17162532 19061943 18056438 16434500 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.55 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.40 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.54 | 16162502 16183991 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.26 | 16510725 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.92 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.63 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
7.63 | 9598899 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.67 | 10378619 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
6.67 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.67 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Homocysteine |
3.05 | 20468076 16297937 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.01 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.91 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.55 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.13 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.68 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.62 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.62 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.62 | 15567936 15994142 15136595 16935488 16264153 19526202 18695136 15668708 17426702 15634643 18382427 15939500 16826403 16322301 17983394 16595493 16096432 15692762 18234424 16115903 17369602 15993339 11325840 18628466 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.62 | 12948864 18497071 17289903 14630087 17018787 17261762 19861407 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.62 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
4.62 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
4.62 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.62 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.01 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.83 | 17687719 10378619 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.31 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.63 | 16227642 18705752 15721981 16011737 15700767 16124888 16192424 16097048 16050911 10355542 15673190 3786805 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.66 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
7.93 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
19.45 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
19.45 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
19.45 | 18971187 19052882 18978308 16288022 16540662 19539802 16502159 17173139 20524982 19822196 17162532 18210153 18665156 17761372 18785209 19701751 16569478 17138121 20214788 21159647 20727157 3084413 20084675 20007298 20432363 18506893 20101231 18393292 19208518 19171122 19383236 17978847 19107877 16779866 19919837 19335982 18494052 18056438 19519916 11831363 19394651 17055752 20512989 20935162 16698587 16328049 16878318 18691550 10672840 17428255 19418558 16935385 16807293 16830150 3581430 18788625 20514400 10737359 16681979 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
19.45 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
19.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
19.45 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
19.45 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
19.45 | 16313753 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.44 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.72 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
6.72 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.45 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.45 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
10.45 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.45 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.28 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.43 | 16612575 17974986 16364871 16269455 16242529 15792986 17007740 16651473 17131338 15505089 16455267 17308081 17928571 17351982 16952015 18627295 17519947 15476868 16278810 17382496 17329180 15811867 16731534 16109756 17924179 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.89 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.17 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.17 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
25.01 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
25.01 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
25.01 | 2727394 17174075 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
25.01 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
25.01 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
25.01 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
15.45 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
15.45 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
15.45 | 18291259 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.80 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 15668235 16354765 12621046 8697196 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
9.54 | 16474422 |
MESH:D003092 |
Colitis |
|
Thalidomide |
9.54 | 16680017 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.78 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.78 | 17725105 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.78 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
6.36 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
6.36 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
6.36 | 17454858 17159606 16303861 18259882 15273666 18509181 16391804 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
6.36 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
6.36 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.42 | 9301478 |
MESH:D003324 |
Coronary Artery Disease |
|
Homocysteine |
3.70 | 16379339 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.66 | 16507316 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.15 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.82 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
2.82 | 9200351 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.09 | 16078585 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.64 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.88 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.88 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.88 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.59 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.59 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.61 | 6884620 9327722 10092053 2869522 7179309 19085960 10915739 15968718 15027814 7440962 19336974 11566570 7120509 3786805 17522070 3732212 15998439 16227642 21278145 16177239 4309450 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.61 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.61 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.61 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.74 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.74 | 11462148 |
MESH:D004487 |
Edema |
|
Mustard Gas |
10.75 | 9260866 11402378 11428647 11428631 |
MESH:D004487 |
Edema |
|
resveratrol |
10.75 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.75 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.88 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.44 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.95 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.95 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
11.95 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.01 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.70 | 17923197 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.01 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.97 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.22 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.22 | 16530937 |
MESH:D017889 |
Exfoliation Syndrome |
|
Homocysteine |
5.55 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
12.30 | 16239168 16045604 15959796 61145 12631006 19224547 12795759 17595544 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.30 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
12.30 | 20387270 21071580 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.44 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.79 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.84 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.84 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.84 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.15 | 12701121 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.07 | 8708960 |
MESH:D005901 |
Glaucoma |
|
Homocysteine |
5.14 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.01 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.01 | 16598420 |
MESH:D005910 |
Glioma |
|
Thalidomide |
3.76 | 16327979 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.43 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.78 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Homocysteine |
10.78 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.78 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.38 | 16707910 16495754 12587719 17875725 16144979 16879835 16244371 16244372 17888722 18006777 14766674 16330681 18674790 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.25 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.76 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.27 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.45 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.74 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.88 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.03 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.65 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
11.65 | 12676792 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
11.65 | 18501091 18180244 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.60 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.38 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.87 | 17188708 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Homocysteine |
4.58 | 17369066 17292331 18234410 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.89 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.75 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.75 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.94 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.17 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.50 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.89 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
15.06 | 18785209 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
15.06 | 11428620 11428647 11428631 8975870 9260866 17524151 11402378 16001271 9357497 |
MESH:D007249 |
Inflammation |
|
resveratrol |
15.06 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.06 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
15.06 | 16134734 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.39 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.87 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.29 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.74 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
13.74 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.74 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.74 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.01 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.86 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.86 | 15610895 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.22 | 16514283 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
6.50 | 19148494 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.50 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.01 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.48 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
4.53 | 18720364 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
4.53 | 18720364 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.05 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.48 | 16087638 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
4.35 | 10473037 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.69 | 21278145 17157831 16221502 11903743 11408273 16943688 17174718 16239168 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.69 | 19638242 20032147 18522880 18665156 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
10.69 | 16943688 17174718 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.50 | 12586293 18395095 18156304 18006644 18481824 12389079 15818738 20821823 18210741 12445418 15362042 16097048 18187930 18472332 18339082 17869086 18166357 12649538 17640975 17481882 16011737 14716496 15123356 17922224 13678700 16136751 16248980 18277467 17766677 14748882 17721639 12666154 15925388 16033810 18412020 14724832 16027843 14620537 18429990 17698563 12445421 16015684 18418968 18420326 18279442 16638106 12546737 18054572 18317297 14512876 17944888 12609069 18251166 14716833 17557913 11481614 17714472 15931870 18705752 15370692 15057751 17900296 16116963 17823541 15650968 18472094 18205269 12632512 15893842 15730626 12898905 12667390 15673190 17631135 15996030 17805973 17525996 15052691 12958196 18263696 18376398 17565644 15338365 15959796 10355542 17761835 18395914 16192424 12741479 17976157 17708605 12632514 15876570 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.50 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.50 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
8.50 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.50 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
8.50 | 15465738 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.94 | 16246199 17285989 15830285 16964402 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.94 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.01 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.56 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
21.03 | 15890375 9163691 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
21.03 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
21.03 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
21.03 | 19427195 21047994 19073162 18977376 12112319 2422723 21278145 19642983 19426721 18648771 16942905 21071580 19638242 19254457 19690152 21167192 18754104 19090486 20452335 20434301 20137499 15175105 12771043 19551842 19499222 15885732 19833225 20405173 18644402 19294768 19812893 10737359 20492335 19850985 20118626 20501860 19256749 18978307 20583210 9163691 19996281 19255062 20101389 2862719 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
21.03 | 19321006 19812893 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
21.03 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
21.03 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
26.85 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
26.85 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
26.85 | 17174075 19126423 17854601 18544905 3124819 18079962 18308698 18093689 9362446 18775883 16842330 19004024 21159647 2563599 19009564 18164116 18253720 18282651 17942915 19539802 16267830 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
26.85 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
26.85 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
26.85 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
26.85 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
7.21 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.21 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
15.07 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
15.07 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
15.07 | 17053015 20135361 18520028 18816296 20464547 20064080 18569708 6695378 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
15.07 | 21163286 6695378 20970405 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
15.07 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
15.07 | 16271038 17909032 6695378 7750092 21163286 9230183 20970405 15390079 11893704 16337739 10545420 20512841 1399818 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
15.07 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
15.07 | 16712894 17306315 19931552 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
15.07 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.35 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.16 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.46 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.46 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.42 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.09 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.51 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.51 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.51 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
13.51 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.33 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.55 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
9.55 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.55 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
9.55 | 12829675 16098027 17089043 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
9.55 | 18505091 17761969 16809738 18332650 16432458 15577320 15577323 16248763 18176117 12374674 |
MESH:D008591 |
Meningomyelocele |
|
Homocysteine |
5.38 | 16602021 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.00 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.24 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.64 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.36 | 15792986 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.93 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.07 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
11.91 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
11.91 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
11.79 | 19549372 18443271 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
11.79 | 16267019 17935668 17164350 16490592 14749477 17049120 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
11.79 | 19112817 17168659 15867202 15744524 19372569 19112201 15741222 15920492 16445831 15939924 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.72 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
7.84 | 19805378 18720364 17611569 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
7.84 | 18720364 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
13.13 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
13.13 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Homocysteine |
13.13 | 17412321 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
13.13 | 17188708 17015251 16525036 16317513 17125593 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.61 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.61 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.13 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.13 | 17141266 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.61 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.26 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.26 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
9.26 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.78 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.78 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.73 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.73 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.58 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.62 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.29 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.87 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.87 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
22.28 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
22.28 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
22.28 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
22.28 | 16859833 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.05 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.90 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
6.90 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.11 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.11 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.58 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.26 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.97 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
9.14 | 16761898 7688884 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
9.14 | 17378895 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.16 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.68 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
9.68 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.99 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.96 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.96 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.96 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
10.96 | 16288038 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.37 | 16540662 |
MESH:D010291 |
Paresis |
|
Thalidomide |
6.15 | 9200351 |
MESH:D010300 |
Parkinson Disease |
|
Homocysteine |
3.52 | 16275827 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.01 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.01 | 17638057 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.66 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.51 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.51 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.15 | 17031469 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.08 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.08 | 11896295 11118676 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.75 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.91 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.91 | 16888761 15897917 16729912 18437689 15749863 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.91 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.91 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.91 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.91 | 17636462 17718901 17804756 15767336 16731767 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.91 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
2.91 | 16729912 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
6.15 | 12755975 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.94 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.87 | 10334151 17894541 17266442 17620002 17720292 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.07 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.43 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.20 | 16317513 17058453 16314181 17520802 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.86 | 17710206 16767912 18313854 15625365 17203757 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.09 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.64 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Homocysteine |
3.09 | 16641680 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.79 | 16096327 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.68 | 16961503 15451306 12880345 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
17.18 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
17.18 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
17.18 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
17.18 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.18 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.42 | 17203757 16767912 15625365 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.32 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.32 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.32 | 15723263 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
4.04 | 15138204 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.35 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.75 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.91 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
6.91 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.53 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.08 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.01 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.01 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.01 | 17306315 11723127 16452187 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.12 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.12 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.99 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.83 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
4.89 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.61 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
11.61 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
9.84 | 17638931 17334414 17678736 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.84 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.29 | 17120751 |